The Disposable Endoscopes Market is experiencing significant growth as healthcare providers increasingly prioritize infection prevention, patient safety, and minimally invasive diagnostic procedures. Growing concerns about cross-contamination associated with reusable endoscopes have accelerated the adoption of single-use devices across hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Unlike conventional reusable systems, disposable endoscopes eliminate the need for reprocessing and sterilization while reducing the risk of hospital-acquired infections and improving workflow efficiency.
The global Disposable Endoscopes Market was valued at USD 2.58 Billion in 2025 and is expected to reach USD 10.47 Billion by 2035, growing at a CAGR of 15.04% from 2026 to 2035. Market expansion is supported by the increasing volume of endoscopic procedures, rising demand for outpatient healthcare services, and continuous innovation in imaging technologies. The growing adoption of flexible disposable endoscopes in pulmonology, gastroenterology, and urology, combined with healthcare investments in infection-control infrastructure, is creating new growth opportunities for manufacturers worldwide.
Gain Actionable Intelligence on the Disposable Endoscopes Market - Request a Sample Report
Key Players
Some of the leading companies operating in the Disposable Endoscopes Market include Ambu A/S, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Olympus Corporation, Pentax Medical (HOYA Corporation), Fujifilm Holdings Corporation, Medtronic, Stryker Corporation, STERIS plc, Baxter International Inc., Verathon Inc., Richard Wolf GmbH, CooperSurgical Inc., Coloplast A/S, Micro-Tech (Nanjing) Co., Ltd., 3NT Medical Ltd., ScoutCam Inc., OTU Medical Inc., Innovex Medical Co., and Flexible Medical Systems Ltd.
Strategic Developments & Industry Innovations
-
In February 2025, Ambu A/S introduced the aScope 5 Uretero, a next-generation single-use ureteroscope equipped with high-definition imaging to improve visualization and procedural efficiency during urological interventions.
-
In February 2025, Karl Storz launched the Slimline C-MAC S, a disposable video laryngoscope designed to enhance airway management while minimizing the risk of cross-contamination in hospital settings.
-
In August 2025, Boston Scientific Corporation expanded its Endura Weight Loss Solutions portfolio by introducing procedures such as endoscopic sleeve gastroplasty and intragastric balloon therapy, highlighting the growing therapeutic applications of disposable endoscopic technologies.
-
Healthcare manufacturers continue investing in high-definition diagnostic imaging, improved ergonomics, enhanced maneuverability, and digital visualization technologies to improve diagnostic accuracy and support more efficient minimally invasive procedures.
-
The increasing shift toward outpatient surgeries and ambulatory care facilities is encouraging broader adoption of disposable endoscopes, enabling healthcare providers to deliver safer procedures while reducing sterilization costs and operational complexity.
Top Players Driving Innovation in the Disposable Endoscopes Market
1. Ambu A/S: Pioneering Single-Use Endoscopy Solutions
Ambu A/S is widely recognized as one of the pioneers in disposable endoscopy technology, offering an extensive portfolio of single-use bronchoscopes, ureteroscopes, laryngoscopes, and visualization systems. The company's products are designed to improve patient safety by eliminating cross-contamination risks while delivering high-quality imaging and reliable clinical performance.
Ambu continues expanding its innovation pipeline through investments in advanced imaging capabilities, ergonomic device design, and minimally invasive technologies. Its strong focus on infection prevention and workflow efficiency has positioned the company as a leading supplier of disposable endoscopes for hospitals, emergency departments, and ambulatory surgical centers worldwide.
2. Boston Scientific Corporation: Expanding Advanced Therapeutic Endoscopy
Boston Scientific Corporation is a global medical technology company known for developing innovative solutions across gastroenterology, pulmonology, and urology. The company continues expanding the clinical applications of endoscopic procedures through advanced therapeutic platforms and minimally invasive technologies.
Its recent introduction of Endura Weight Loss Solutions reflects the growing role of endoscopy beyond diagnostics into therapeutic interventions. By investing in physician education, advanced imaging technologies, and procedure optimization, Boston Scientific continues strengthening its position in the rapidly evolving disposable endoscope market.
3. Karl Storz GmbH & Co. KG: Driving Innovation in Endoscopic Visualization
Karl Storz GmbH & Co. KG remains one of the world's leading manufacturers of endoscopic visualization systems and minimally invasive surgical technologies. The company continues expanding its portfolio of disposable devices designed for airway management device, surgical visualization, and critical care applications.
Through continuous product development and precision optical technologies, Karl Storz provides healthcare professionals with reliable visualization solutions that improve procedural accuracy and patient safety. Its focus on high-performance imaging systems continues supporting the increasing demand for single-use endoscopic technologies across global healthcare facilities.
How the Disposable Endoscopes Market Is Transforming Modern Healthcare
The Disposable Endoscopes Market is reshaping modern healthcare by providing safer, more efficient alternatives to reusable endoscopic equipment. More than 50 million endoscopic procedures are performed globally every year, and the adoption of single-use devices continues to increase as hospitals seek to reduce healthcare-associated infections and simplify clinical workflows. Flexible disposable endoscopes have become widely used across pulmonology, gastroenterology, and urology, while rigid disposable devices continue gaining traction in orthopedic and gynecological procedures.
Growing procedural volumes, expanding outpatient care, and increasing awareness of infection prevention are expected to sustain long-term market growth. North America currently dominates global adoption due to advanced healthcare infrastructure and strong infection-control initiatives, while Asia Pacific is projected to register the fastest growth as healthcare investments, hospital expansion, and procedural volumes continue rising across the region.
Leading manufacturers including Ambu A/S, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Olympus Corporation, and Fujifilm Holdings Corporation continue investing in next-generation imaging technologies, improved device performance, and innovative disposable platforms. As healthcare providers increasingly prioritize patient safety, operational efficiency, and minimally invasive treatment, disposable endoscopes are expected to become a standard component of endoscopic care worldwide, supporting improved clinical outcomes and reducing the risks associated with reusable medical devices.
